Billionaire surgeon Patrick Soon-Shiong, who just bought the LA Times, is a controversial figure in medicine
The transplant expert turned entrepreneur, who is worth US$7.8 billion, has been accused of hyping medical claims in the past
Patrick Soon-Shiong, a billionaire doctor and medical entrepreneur, has been revealed as the buyer of the Los Angeles Times newspaper in a US$500 million deal.
A respected transplant surgeon from the University of California at Los Angeles turned businessman and philanthropist, Soon-Shiong first became famous for inventing an important cancer drug.
Chicago-based Tronc, parent company of the LA Times, on Wednesday announced the sale of The Times, the San Diego Union-Tribune and the Spanish-language Hoy to Soon-Shiong’s investment firm Nant Capital for US$500 million in cash. In addition to the purchase price, the deal includes the assumption of US$90 million in pension liabilities.
“We look forward to continuing the great tradition of award-winning journalism carried out by the reporters and editors of the Los Angeles Times, the San Diego Union-Tribune and the other California News Group titles,” Soon-Shiong said in a statement.
But Soon-Shiong, with a personal net worth of US$7.8 billion has also been the subject of media investigations, criticism from the medical community and a handful of lawsuits.